Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

MoonLake Immunotherapeutics (MLTX) Pension (2021 - 2026)

MoonLake Immunotherapeutics' Pension history spans 6 years, with the latest figure at $353000.0 for Q1 2026.

  • Quarterly Pension fell 34.14% to $353000.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $353000.0 through Mar 2026, down 34.14% year-over-year, with the annual reading at $621000.0 for FY2024, 75.1% down from the prior year.
  • Pension came in at $353000.0 for Q1 2026, down from $549000.0 in the prior quarter.
  • In the past five years, Pension ranged from a high of $2.5 million in Q4 2023 to a low of $4985.0 in Q3 2022.
  • The 5-year median for Pension is $536000.0 (2025), against an average of $604359.1.
  • Year-over-year, Pension surged 5023.35% in 2023 and then crashed 75.1% in 2024.
  • MoonLake Immunotherapeutics' Pension stood at $1.3 million in 2022, then soared by 88.65% to $2.5 million in 2023, then plummeted by 75.1% to $621000.0 in 2024, then dropped by 11.59% to $549000.0 in 2025, then plummeted by 35.7% to $353000.0 in 2026.
  • Per Business Quant, the three most recent readings for MLTX's Pension are $353000.0 (Q1 2026), $549000.0 (Q3 2025), and $574000.0 (Q2 2025).